Patricia Bononi is an Endocrinology/Metabolic physician affiliated with Allegheny Health Network. OpenAlex indexes 26 publications with 710 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4815 Liberty Ave Ste 215
Pittsburgh, PA 152242156
Telephone
412-578-5901Provider last certified this registry record 8 Oct 2020.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202517 payments$12,132openpaymentsdata.cms.gov ↗
- Dexcom, Inc.Program year20252 payments
- Sequel Med Tech, LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
58%Insulin Analog20.4%Lantus Solostar30%Toujeo Solostar13%Humalog Kwikpen U-10012%Novolog Flexpen9%Basaglar Kwikpen U-1008%Tresiba Flextouch U-2008%Humalog6%Novolog4%Tresiba Flextouch U-1004%Admelog Solostar2%Fiasp Flextouch2%Humalog Kwikpen U-2002%Part D<11 patientsGLP-1 receptor agonist16.1%Ozempic52%Trulicity22%Mounjaro22%Rybelsus3%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
22.1%l-Thyroxine20.6%Levothyroxine Sodium67%Synthroid30%Levoxyl3%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.7%Methimazole100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
17.1%Statin8.3%Atorvastatin Calcium60%Rosuvastatin Calcium19%Simvastatin13%Pravastatin Sodium8%Part D<11 patientsAngiotensin receptor blocker (ARB)2.5%Losartan Potassium100%Part D≥24 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Indications and Outcomes of Thyroid Ultrasounds Obtained at Primary Care Clinics Within a Large Health System
AACE Endocrinology and Diabetes
2026 - Diabetes Ketoacidosis and Bilateral Cerebral Venous Sinus Thrombosis
Annals of Internal Medicine Clinical Cases
2025 - Gastrointestinal and Nutritional Support, Endocrine, and Hematological Considerations in Sepsis
Critical Care Nursing Quarterly
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Manzi, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”